SCHEMBL1633419

SCHEMBL1633419

NC(=O)c1cccc(COc2cccc3cnc(Nc4ccc(S(N)(=O)=O)cc4)nc23)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 2/20 0.44
PTK2 Q05397 5/20 0.44
SYK P43405 3/20 0.43
IKBKB O14920 2/20 0.43
PPIA P62937 1/20 0.43
CDK2 P24941 5/20 0.42
CDK1 P06493 4/20 0.42
CCNA2 P20248 1/20 0.42
JAK2 O60674 2/20 0.42
KDR P35968 3/20 0.42
CDC7 O00311 1/20 0.42
PLK4 O00444 1/20 0.42
CHEK1 O14757 1/20 0.42
AURKA O14965 1/20 0.42
DCLK1 O15075 1/20 0.42
PDPK1 O15530 1/20 0.42
DAPK3 O43293 1/20 0.42
ROCK2 O75116 1/20 0.42
MAP4K4 O95819 1/20 0.42
PAK4 O96013 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1634688 0.91 RXFP1 (0.45) NTRK1PTK2SYKPPIACDK2
SCHEMBL1633413 0.85 CA1 (0.47) NTRK1PTK2SYKIKBKBCDK2
SCHEMBL1634183 0.84 EGFR (0.52) NTRK1PTK2IKBKBCDK2CDK1
SCHEMBL1632931 0.82 CA2 (0.50) PTK2IKBKBPPIACDK2CDK1
SCHEMBL1632971 0.81 NTRK1 (0.42) NTRK1PTK2IKBKBCDK2CDK1
SCHEMBL1633411 0.80 MTOR (0.50) SYKIKBKBCDK2CDK1CCNA2
SCHEMBL1632411 0.79 CDK2 (0.41) NTRK1PTK2IKBKBCDK2CDK1
SCHEMBL1633872 0.76 CDK2 (0.52) NTRK1PTK2IKBKBCDK2CDK1
SCHEMBL1632775 0.75 MAPK10 (0.51) SYKIKBKBCDK2CDK1JAK2
SCHEMBL1633821 0.74 STK4 (0.52) IKBKBCDK2CDK1JAK2AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed